RecruitingNCT07663669
Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection
Sponsor
Centre Hospitalier Universitaire de Besancon
Enrollment
31 participants
Start Date
Jun 1, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Kidney transplant recipients followed at the University Hospitals of Besançon and Lille between September 1, 2016, and August 31, 2023
- Patients with antibody-mediated rejection (as confirmed by histological analysis of the renal biopsy)
- Rejection treated with extracorporeal photopheresis
- Subjects who do not object to the use of their personal data and/or biological samples
- Subjects affiliated with, or beneficiaries of, the French social security system
Exclusion Criteria7
- Patients with acute rejection
- Pregnant women, women in labor, or breastfeeding mothers
- Individuals deprived of liberty by judicial or administrative decision; individuals receiving compulsory psychiatric care; or individuals admitted to a healthcare or social institution for reasons other than research participation
- Minors
- Adults under legal protection or unable to provide informed consent
- Subjects without health insurance coverage
- Subjects currently within an exclusion period from another study, or as listed in the "national volunteer registry"
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07663669